Stockhub

Medifron DBT Co., Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 08:1908:19, 22 September 2022 95.149.241.133 talk 481 bytes +481 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Medifron DBT Co., Ltd., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer's disease (AD) and neuropathic pain treatments, and AD diagnostics. The company was formerly known as Legend Technologies Inc. and changed its name to Medifron DBT Co., Ltd. in 2006. Medifron DBT Co., Ltd. was incorporated in 1997 and is based in Seoul, South Korea. == References and notes == Category:Thesis __I..."
Retrieved from "https://stockhub.co/research/Medifron_DBT_Co.,_Ltd."